Chapter 1. ECMO (EXTRACORPOREAL MEMBRANE OXYGENATION)  MARKET– Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. ECMO (EXTRACORPOREAL MEMBRANE OXYGENATION)   MARKET– Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. ECMO (EXTRACORPOREAL MEMBRANE OXYGENATION)  MARKET– Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. ECMO (EXTRACORPOREAL MEMBRANE OXYGENATION)   MARKET- Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. ECMO (EXTRACORPOREAL MEMBRANE OXYGENATION)   MARKET- Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. ECMO (EXTRACORPOREAL MEMBRANE OXYGENATION)   MARKET– By Type

6.1 Veno-Venous

6.2. Veno-Arterial

Chapter 7. ECMO (EXTRACORPOREAL MEMBRANE OXYGENATION)   MARKET– By Application

7.1 Pediatric

7.2. Neonatal

7.3. Adult

Chapter 8. ECMO (EXTRACORPOREAL MEMBRANE OXYGENATION)  MARKET– By Region

8.1. North America

8.2. Europe

8.3.The Asia Pacific

8.4.Latin America

8.5. Middle-East and Africa

Chapter 9. ECMO (EXTRACORPOREAL MEMBRANE OXYGENATION) MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)

9.1. Company 1

9.2. Company 2

9.3. Company 3

9.4. Company 4

9.5. Company 5

9.6. Company 6

9.7. Company 7

9.8. Company 8

9.9. Company 9

9.10. Company 10